NuVision
Emily is experienced in both academic and applied scientific research. She holds a PhD in Tissue Engineering from the University of Nottingham where she was part of the EPSRC doctor training program in regenerative medicine.
Emily was previously a post-doctoral research associate in Academic Ophthalmology at the University of Nottingham where she is focused on the development of Omnigen for acute ocular surface trauma.
This person is not in the org chart
NuVision
NuVision™ is a biotechnology research and development spin out company from the University of Nottingham